Relapsed/Refractory Immune Thrombocytopenia
1 clinical trials · Condition
◉ Watch Relapsed/Refractory Immune Thrombocytopenia
| Record | Firm | Date |
|---|---|---|
| The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune Thrombocytopenia (NCT05599880) | Seoul National University Hospital | 2023-07-07 |
Track Relapsed/Refractory Immune Thrombocytopenia automatically
Every clearance here is in the API, with alerts when new ones post.